Researchers conducted a post hoc analysis of a multicenter study in 13 intensive care units in Europe. They used prospective surveillance data and a mathematical model to estimate transmission capacities and single-admission reproduction numbers of Escherichia coli and non-E. coli Enterobacteriaceae — all resistant to expanded-spectrum cephalosporins.
The study shows of 11,420 patients included in the analysis the admission prevalence was 3.8 percent for non-E. coli Enterobacteriaceae, or non-EcE, and 3.3 percent for E. coli. Around 74 percent of non-EcE admissions were for Klebsiella pneumoniae. The acquisition rates were 7.4 and 2.6 per 100 admissions at risk for non-EcE and E. coli, respectively.
The estimated transmission capacity of non-EcE was 3.7 times higher than that of E. coli, resulting in single-admission reproduction numbers of 0.17 for non-EcE and 0.047 for E. coli.
More articles on healthcare quality:
Risk assessment scale accurately predicts pressure injuries in pediatric patients, study finds
Hygiene tripods, algorithms and more: How St. Louis University Hospital is battling flu season
86 infected with norovirus at 2018 Olympic Winter Games
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
